Document is current
Any future updates will be listed below
-
Authors
Termannsen, Anne-Ditte https://orcid.org/0000-0002-1580-1252
Bjerre, Natasja
Hansen, Gitte Stage
Jalking, Lea
Færch, Kristine
Hempler, Nana Folmann
Quist, Jonas Salling
Varming, Annemarie
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF200C0065836)
Diabetesforeningen
Danish Diabetes and Endocrine Academy (NNF17SA0031406)
Copenhagen University
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 2 October 2025
First Online: 6 November 2025
Declarations
:
: The study was approved by Ethics Committee of Capital Region of Denmark (H-21041830).
: Not applicable.
: KF has received research grants from Novo Nordisk A/S, Unilever A/S, and AstraZeneca A/S; holds shares in Novo Nordisk A/S and ChemoMetec A/S; and is currently employed by Novo Nordisk A/S. JSQ has received funding from Novo Nordisk A/S for other studies. ADT, NB, GSH, LJ, NFH, and AV report no potential conflicts relevant to this article.
